2020
DOI: 10.1002/adtp.202000129
|View full text |Cite
|
Sign up to set email alerts
|

Stimuli‐Responsive Biomaterials for Vaccines and Immunotherapeutic Applications

Abstract: The immune system is the key target for vaccines and immunotherapeutic approaches aimed at blunting infectious diseases, cancer, autoimmunity, and implant rejection. However, systemwide immunomodulation is undesirable due to the severe side effects that typically accompany such strategies. In order to circumvent these undesired, harmful effects, scientists have turned to tailorable biomaterials that can achieve localized, potent release of immune‐modulating agents. Specifically, “stimuli‐responsive” biomateria… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 127 publications
(129 reference statements)
0
21
0
Order By: Relevance
“…The EPR effect describes a phenomenon where nanoparticles tend to accumulate within tissues with leaky vasculature, such as sites of inflammation, or within tumors [85]. Membrane surfaces of the nanocarriers can also be customized through ligation of antibodies, peptides, and receptors, or incorporation of environmentally sensitive bonds [86] to facilitate active targeting of specific tissue compartments [84]. Nanocarriers can also function as drug depots with programmable release kinetics [84].…”
Section: Biomaterial-based Immunotherapies For Ramentioning
confidence: 99%
See 4 more Smart Citations
“…The EPR effect describes a phenomenon where nanoparticles tend to accumulate within tissues with leaky vasculature, such as sites of inflammation, or within tumors [85]. Membrane surfaces of the nanocarriers can also be customized through ligation of antibodies, peptides, and receptors, or incorporation of environmentally sensitive bonds [86] to facilitate active targeting of specific tissue compartments [84]. Nanocarriers can also function as drug depots with programmable release kinetics [84].…”
Section: Biomaterial-based Immunotherapies For Ramentioning
confidence: 99%
“…Moreover, the potential for customizability is vast. Altering the material used for fabrication of NPs and MPs can bestow dynamic characteristics to the drug carrier system that allows for targeting of different environmental cues or specific disease states [86], or even potentially conferring intrinsic characteristics into the particle itself [102]. For example, many gut-derived molecules exert immunosuppressive effects and are garnering interest for their potential to be fabricated into particles that possess tolerance-inducing effects [102], and poly-conjugated aspirin particles have been used to confer innate anti-thrombus activity into the particle itself [103].…”
Section: Biomaterial-based Immunotherapies For Ramentioning
confidence: 99%
See 3 more Smart Citations